- Coordinator
- Fundacio Privada Institut D'investigacio Oncologica De Vall-Hebron (vhio), Spain
- Runs
- 1 January 2025 to 30 June 2030
- Status
- Running
- EU funding
- €1.7m
- Total cost
- —
- Partners
- 17 organisations in 6 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101179122
What the project is doing
In the project's own words, from its summary on CORDIS.
The proposed “VHIO International postDoctoral programme for translAtional research” (VIDA) aims at enabling outstanding junior scientists of all nationalities to develop a competitive research project at VHIO, an international reference center for personalized medicine in oncology that thanks to its pioneering model of multidisciplinary and translational research is among the leading comprehensive cancer centers in Europe.
VIDA aims to nurture excellent postdoctoral fellows to advance research, personalised medicine in oncology and patient health care in Europe. Following a fair, merit-based and inclusive recruitment process, the programme will hire 12 postdoctoral researchers to carry out a research project that will benefit from a stimulating and creative environment, career development and mentoring schemes, and access to high-end technologies and facilities.
Importantly, they will benefit from a tailored advanced training programme on the latest technologies, open science, gender and innovation, and from a specific mentoring scheme, with the opportunity to build valuable national and international networks with different actors in academia, hospitals, industry, editors and universities. VIDA counts on the support and collaboration of 15 associated partner organisations. The trained fellows will be equipped with skills and knowledge to tackle relevant clinical and research questions, and ultimately pursue new approaches to diagnose and treat oncology diseases.
Overall, the VIDA Programme will provide fellows skills and competences for developing a successful career in both the academic and non-academic sector and VHIO is a unique institute to bring them the possibility of contributing to improve prevention, early diagnosis, monitoring and treatment of cancer patients; key intervention areas of the Horizon Europe Mission on Cancer.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Fundacio Privada Institut D'investigacio Oncologica De Vall-Hebron (vhio) | Barcelona | Spain | Coordinator |
| Deutsches Krebsforschungszentrum Heidelberg | Heidelberg | Germany | Associatedpartner |
| Departament de Recerca i Universitats_Generalitat de Catalunya | Barcelona | Spain | Associatedpartner |
| Fundacio D'estudis I Recerca Oncologica (fero) | Barcelona | Spain | Associatedpartner |
| Fundacio Barcelonabeta Brain Research Center | Barcelona | Spain | Associatedpartner |
| Fundacio Centre De Regulacio Genomica | Barcelona | Spain | Associatedpartner |
| Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I Sunyer | Barcelona | Spain | Associatedpartner |
| Fundacio Hospital Universitari Vall D'hebron - Institut De Recerca | Barcelona | Spain | Associatedpartner |
| Fundacio Institut De Bioenginyeria De Catalunya | Barcelona | Spain | Associatedpartner |
| Fundacio Institut De Recerca Biomedica (irb Barcelona) | Barcelona | Spain | Associatedpartner |
| Fundacion Privada Instituto De Salud Global Barcelona | Barcelona | Spain | Associatedpartner |
| Fundacion Universitaria San Pablo-Ceu | Madrid | Spain | Associatedpartner |
| Prisma Asociacion Para La Diversidad Afectivo-Sexual Y De Genero En Ciencia Tecnologia E Innovacion | Pamplona | Spain | Associatedpartner |
| Institut Gustave Roussy | Villejuif | France | Associatedpartner |
| Omniscope Limited | Mosta | Malta | Associatedpartner |
| Karolinska Institutet | Stockholm | Sweden | Associatedpartner |
| Springer Nature Limited | Basingstoke Hants | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI